Global Automated Whole-Breast Ultrasound Market By Product Type: (Automated Breast Ultrasound System, Automated Breast Volume Scanner) By Application: (Screening, Pre-Operative Evaluation) By End-User: (Hospitals, Ambulatory Surgical Units, Other End-Users), by Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Automated Whole-Breast Ultrasound System Market Introduction:

The global Automated Whole-Breast Ultrasound market is projected to reach a valuation of USD 557.23 Mn by 2032 at a CAGR of 15.50%, from USD 114.19 Mn in 2021.

The Automated Breast Ultrasound System (ABUS) is designed to obtain ultrasound images with the help of a broadband transducer which is used to scan the whole breast. It provides 3D images and detects cancer in dense breast tissue. It enables quicker scan time and reduces operator dependence. It also increases the reproducibility, consistency, reliability, and sensitivity of each complete breast ultrasound diagnosis. Automated whole-breast ultrasound is a computer-based system used to record and monitor the whole breast to diagnose cancer.

The automated whole-breast ultrasound system is considered to be a superior option to mammography when it comes to detecting cancer. The automated whole-breast ultrasound system provides images in the range of 7 to 12 MHz. ABUS can overcome some of the limitations of handheld ultrasound systems, as it allows structured image acquisition by non-specialists, whole-breast evaluation, multiplanar reformation, and temporal comparison. Therefore, ABUS appears more suitable and more affordable as a supplemental screening technique.
Detailed Segmentation:

The automated whole-breast ultrasound market is segmented on the basis of – product type, application, end-user, and region.

By Product Type:

• Automated Breast Ultrasound System
• Automated Breast Volume Scanner

By Application:

• Screening
• Pre-Operative Evaluation

By End-User:

• Hospitals
• Ambulatory Surgical Units
• Diagnostic Centres
• Other End-Users

By Region:

• North America
• Europe
• APAC
• South America
• MEA

Market Dynamics:

Increasing awareness of breast cancer symptoms, improved radiology, and surging extensive research & development activities for upgraded imaging techniques are boosting the automated whole-breast ultrasound market economically. Increasing government initiatives toward breast cancer awareness also acts as a driver for this market. However, there are various regulations imposed by respective governments on product approvals that could potentially derail this market’s economic growth rate. A lack of medical experts and unfavorable reimbursement policies, especially in developing and underdeveloped economies, are expected to further pose challenges for this market. Automated whole-breast ultrasound requires high manufacturing costs of Magnetic Resonance Imaging (MRI), exposure to radiation, and high maintenance costs, all elements that may hinder market growth prospects for this global industry.

Key Players:

• Abcam PLC Hitachi Ltd.
• Siemens Healthcare GmbH
• Canon Medical System Corporation
• General Electric Company
• Koninklijke Philips N.V.
• Aspect Imaging Ltd.
• Bruker
• Aurora Healthcare US Corporation
• Fonar Corp
• Esaote SPA
• Neusoft Corporation.
• Toshiba Corporation
• Sanrad Medical Systems Private Limited
• Fujifilm Holdings Corporation
• Onex Corporation
• Other Key Players

Key Developments:

Siemens Healthcare introduced a ground-breaking innovation, the Automated Breast Volume Scanner (ABVS), to provide images of the volume of breasts using high-frequency sound waves. This enhanced breast cancer screening in women with denser breast tissue allowing a radiologist to better interpret test results.

In 2019, Healthcare and Premier Inc. joined forces to develop a model that could offer breast cancer diagnosis and treatment on the same day.

For the Automated Whole-Breast Ultrasound System Market research study, the following years have been considered to estimate the market size: